A systematic review of 52,501 participants found that 45.3% of type 2 diabetes patients have micronutrient deficiencies, with ...

Treatment can cause type 2 diabetes ... Many people manage type 2 diabetes with diet and exercise, but some may need medication to help keep their blood sugar levels within the target range.

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, ...

About 828 million adults around the world have diabetes, and 90% have type 2 diabetes ... a calorie-restricted diet. “SGLT-2 inhibits are a class of medications that inhibit glucose reabsorption ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents-have been ...

Type 2 diabetes is a leading cause of chronic kidney disease, which affects more than 1 in 7 U.S. adults. The new approval ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Overweight and obese adults caused their diabetes to go into remission by following a calorie-restricted diet and taking the ...

A groundbreaking medication capable of preventing type 2 diabetes ... and treatment approaches, including the most recent medications and technologies that empower people with diabetes to lead ...

In this retrospective study of patients with comorbid type 2 diabetes mellitus and tobacco use disorder (TUD), semaglutide ...

A study from The BMJ found 44% of participants reversed type 2 diabetes with a calorie-restricted ... for two months after stopping diabetic medications. The combination strategy also improved ...